Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31097218 | 1.00 | TSHR (0.54) | TSHRALDH1A1ABCC4MAPTLMNA | |
| SCHEMBL6890731 | 1.00 | TSHR (0.54) | TSHRALDH1A1ABCC4MAPTLMNA | |
| SCHEMBL14918646 | 0.98 | TSHR (0.50) | TSHRALDH1A1ABCC4MAPTLMNA | |
| SCHEMBL31097224 | 0.90 | TSHR (0.50) | TSHRALDH1A1ABCC4MAPTLMNA | |
| SCHEMBL10843321 | 0.89 | TSHR (0.67) | TSHRALDH1A1ABCC4MAPT | |
| SCHEMBL10841407 | 0.84 | TSHR (0.73) | TSHRALDH1A1ABCC4MAPT | |
| SCHEMBL10844537 | 0.84 | TSHR (0.73) | TSHRALDH1A1ABCC4MAPT | |
| SCHEMBL10841635 | 0.84 | TSHR (0.73) | TSHRALDH1A1ABCC4MAPT | |
| SCHEMBL8770117 | 0.79 | TSHR (0.45) | TSHRALDH1A1 | |
| SCHEMBL10404934 | 0.79 | TSHR (0.31) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4572791-A | REACTING ALPHA-OLEFIN WITH DI-OR TRIALKYLSILANE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1986-02-25 | — | — | US | disclosed |